SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (762)5/14/1998 5:37:00 AM
From: SnowShredder   of 998
 
The FDA is in a bind because they are getting a lot of pressure from the public about this drug, but you have to think that there decision on this case will set precedence for future studies. CEPH and CHIR showed blatant disregard for the FDA's recommendations...thus I would not be surprised if they denied approval. If they do approve myo then in the review committees lose credibility which will probably lead to more disrespect...the pharms will say but what about myo? and will try to get their drug approved the same way even if it has bad side effects. A bad pattern would form and the pharms would have the upper hand over the FDA.

I feel for the ALS patients and hope for them that it would be approved, but I would not be surprised to see the FDA deny myo to set precedence that we are in charge...listen to our recommendations...and to keep the pharms in check. <eom>

Best of Luck,

Where'd He Go?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News